U.S. House · 118th Congress · H.R. 6897
Synthetic Biology and Active Pharmaceutical Ingredients Act
To require the Secretary of Defense to establish a pilot program to evaluate novel pharmaceutical manufacturing technologies to reduce the reliance of the Department on foreign manufacturers for active pharmaceutical ingredients and key starting materials.
Follow
Log in to follow this bill and get an email when there’s a new vote (premium).
- Sponsor
- Elissa SlotkinD-MI-7
- Introduced
- December 22, 2023, in the House
- Issue areas
- Policy area
- Health (from the Congressional Research Service)
- Full text and actions
- congress.gov
Votes on this bill (0)
Neither the House nor the Senate has held a roll-call vote on this bill.
Cosponsors (1)
1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these
Original cosponsors
- Mike GallagherR-WI-8